Press Releases
Press
09
Sep
Sep
2019
...
Press
29
Jan
Jan
2019
The Lung Cancer Master Protocol (Lung-MAP), the first precision medicine trial in lung cancer supported by the National Cancer Institute (NCI),...
Press
29
Feb
Feb
2016
Lung-MAP, the most collaborative and comprehensive lung cancer clinical trial active in the U.S., uses a targeted screening approach to match...
Press
10
Mar
Mar
2015
On March 4, 2015, the U.S. Food and Drug Administration (FDA) announced that it had approved Opdivo (nivolumab) for the treatment of patients with...
Press
03
Dec
Dec
2014
Trial will Close One of Five Trial Sub-Studies: Other four sub-studies of targeted treatments for squamous cell lung cancer will continue to...
Press
06
Nov
Nov
2014
...
Press
23
Jul
Jul
2014
Groundbreaking study in squamous cell lung cancer opens at more than a hundred and fifty new locations
Press
16
Jun
Jun
2014
Lung-MAP is a multi-drug, multi-arm, biomarker-driven clinical trial for patients with advanced squamous cell lung cancer.
